{"id":739152,"date":"2026-02-03T08:39:10","date_gmt":"2026-02-03T08:39:10","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/739152\/"},"modified":"2026-02-03T08:39:10","modified_gmt":"2026-02-03T08:39:10","slug":"ozempic-blindness-is-there-a-link","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/739152\/","title":{"rendered":"Ozempic Blindness: Is There a Link?"},"content":{"rendered":"

If you\u2019re using\u00a0Ozempic\u00ae<\/a>\u00a0or other GLP-1s, you\u2019re probably familiar with potential side effects like \u201cOzempic face<\/a>\u201d and \u201cOzempic butt<\/a>.\u201d<\/p>\n

Advertisement<\/p>\n

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy<\/a><\/p>\n

But what about \u201cOzempic blindness\u201d?<\/p>\n

Vitreoretinal surgeon Katherine Talcott, MD<\/a>, explains what we know about how weight loss drugs may impact your vision.<\/p>\n

Does Ozempic cause blindness?<\/p>\n

\u201cOzempic blindness\u201d isn\u2019t an actual medical diagnosis, notes Dr. Talcott.<\/p>\n

\u201cThere\u2019s been a lot of research on whether medications like Ozempic have any adverse impacts in the eye,\u201d she says. \u201cThere\u2019s a possible association with nonarteritic anterior ischemic neuropathy (NAION), which can cause vision to decrease.\u201d<\/p>\n

One study<\/a> compared people who were on Ozempic with people who weren\u2019t taking the medication. The results showed an increased risk of having NAION in people who were on Ozempic.<\/p>\n

\u201cThat caused a fair amount of concern. But it\u2019s important to note the researchers found an association, not necessarily a causation, between the two,\u201d clarifies Dr. Talcott, who was a co-author on a study<\/a> that found no association between Ozempic and NAION.<\/p>\n

It\u2019s worth noting that organizations, including the American Academy of Ophthalmology<\/a>, have advised healthcare providers to discuss the potential link with patients on Ozempic or other GLP-1s.<\/p>\n

\u201cBut it\u2019s not recommended that people stop those medications,\u201d stresses Dr. Talcott. \u201cYou should have a discussion with your primary care doctor about the risks and benefits. Most eye doctors feel that the benefits of these drugs outweigh any potential risk, in terms of the eye.\u201d<\/p>\n

One of those potential benefits? Some early studies<\/a> show that Ozempic may decrease the risk of developing age-related macular degeneration (AMD)<\/a>.<\/p>\n

Ozempic blindness symptoms<\/p>\n

If you\u2019re experiencing NAION, you may notice:<\/p>\n